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We have studied tumorigenic transformation of mouse 
tissue culture cells by bovine papillomavirus (BPV) as a 
model of papillomavirus-induced cell proliferation. 
When BPV or its 7.9-kb full-length viral DNA genome 
induces focal transformation of mouse calls, the viral 
DNA is maintained in the transformed cells as multiple 
extrachromosomal copies. The transforming capacity 
was initially localized to a 69% subgenomic fragment of 
the viral DNA genome. We have further characterized 
the BPV DNA sequences that can encode the transform­
ing function by generating and analyzing the transform­
ing activity of a series of BPV DNA deletion mutants. 
The results indicated that two discontinuous segments 
of the viral DNA are required for transformation. One 
segment, near the 5' end of the 69% transforming frag­
ment, probably represents a control element of the viral 
DNA. The second segment, which lies within the 3' end 
of the 69% fragment, encodes transforming sequences 
of the viral DNA. A retroviral control element (the long 
terminal repeat DNA of Harvey murine sarcoma virus) 
will activate the 2.3-kb segment at the 3' end of the 69% 
fragment to transform the mouse cells. 
Papillomaviruses (PV), which form a subgroup of the papo­
vaviruses ( papova = papilloma, polyoma, and vacuolating vi­
ruses), induce benign epithelial proliferations (warts, papillo­
mas) that may undergo malignant conversion in certain settings 
[1-3]. Their virions (viral particles) are small (55 nm in diam­
eter), nonenveloped spheres. The PV genome is an 8000-nu­
cleotide-Iong (8 kb), circular, double-stranded DNA molecule. 
PVs are widely distributed among mammalian species, in­
cluding humans, rabbits, cows, and dogs. However, each virus 
induces papillomas only in the species that is its natural host. 
Virus replication (the production of progeny virions) is confined 
to nuclei of the upper epidermal layers. A few copies of the 
viral DNA genome are thought to be present in the cells of the 
lower epidermal layers, including basal cells, but no data di­
rectly support this conjecture. 
Progress in studying the biology of PV has been hampered 
by the lack of a suitable tissue culture system for propagation 
of these viruses. While complete replication of PV has not yet 
been achieved in vitro, we have developed an in vitro cell 
transformation assay for bovine papilloma viruses (BPV) types 
1 and 2 [4]. These latter viruses induce fibropapillomas, while 
infection by most PVs (including all known human PVs) results 
in papillomas. Even with BPV -induced fibropapillomas, virus 
replication is confined to the epidermal cells, although viral 
DNA is found in the dermal fibroblasts. The BPV-mediated 
transformation of tissue culture cells is probably related to the 
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capacity of these viruses to infect dermal fibroblasts in vivo, 
since attempts to achieve similar results in vitro using PVs 
that induce papillomas have been negative in the hands of most 
investigators. There is, however, a recent report that tissue 
culture cells that can be transformed by BPV can also be 
transformed by (Shope) cottontail rabbit papillomavirus 
(CRPV), a virus that does not affect dermal fibroblasts in vivo 
[5]. Our in vitro studies, which form the basis of this report, 
have been limited to BPV-1. 
In the BPV tissue culture cell transformation assay, BPV 
virions or viral DNA induce inappropriate proliferation of 
selected rodent tissue culture cell lines [4,6]. Although con­
fluent mono layers of these cell lines are ordinarily contact­
inhibited, infection by virions or "transfection" by viral DNA 
overcomes this inhibition. At confluence, each cell that has 
stably taken up the viral DNA and the progeny of this cell will 
continue to proliferate; since these "transformed" cells still 
remain adherent to each other, they will pile up in a small area 
of the Petri dish to form a "focus" of transformed cells. Provided 
that only a small number of the cells in the dish have been 
infected or transfected, the number of foci can readily be 
counted to provide an estimate of the number of initially 
infected or transfected cells. The cells in the foci are fully 
transformed, in that they are capable of anchorage-independent 
growth and can form tumors in nude mice. The state of the 
viral DNA in the transformed cells is similar to that found in 
the dermal fibroblasts of BPV -induced fibropapillomas: Each 
cell contains multiple copies of replicating circular extrachro­
mosomal viral DNA, but no virion proteins are synthesized 
[7,8]. These cells therefore do not release progeny virus. 
In vitro cell transformation by BPV is probably induced by 
viral functions that are closely related to those by which PVs 
induce their warts in vivo, although no evidence directly sup­
ports this assumption. There is no correlation in vivo between 
the size of a wart and the number of viral particles within it. 
This observation suggests that viral functions that may not be 
related directly to the synthesis of progeny virions are the 
essential viral determinants of abnormal cell proliferation in 
warts. Comparative DNA sequence analysis of BPV-1 and 
HPV-l (two PVs that are distantly related at the nucleotide 
level) suggests further that the genetic organization of both 
PVs are very similar [9]. It therefore is likely that characteri­
zation of BPV functions may be of relevance to other PV s. 
These considerations have led us to undertake the studies 
related to in vitro transformation by BPV that form the basis 
of this report [10]. 
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METHODS 
Construction of BPV Deletion Mutants 
Containment conditions used in these studies followed those speci­
fied by the National Institutes of Health Recombinant DNA Research 
Guidelines. The starting material for the deletion mutants was the full­
length 7.9-kb BPV -1 DNA genome cloned at the BamHI site in pBR322 
(clone 8-2) [11]. To generate the mutants, the method of Heffron et al 
[12] was employed with minor modification. The intact circular 12.2-
kb clone 8-2 DNA was subjected to partial digestion by HaeIII retriction 
endonuclease, whose recognition sequence is present multiple times in 
BPV DNA [13]. The partially digested linearized DNAs were subjected 
to agarose gel electrophoresis, and DNA fragments from 8 to 12 kb 
were selected by electroelution. Octamers (New England Biolab) con­
taining the XhoI recognition sequence (which is not present in either 
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FIG 1. Southern blot analysis of BPV 
DNA deletion mutants reported in [10J. 
The DNA from the various deletion 
clones was digested with the indicated 
enzymes, subjected to agarose gel elec­
trophoresis, transferred to nitrocellulose 
filters, and hybridized with a 32P-labeled 
SPV DNA probe. The probe was pre­
pared from wild-type BPV-pBR (clone 
8-2) by BamHI digestion, agarose gel 
electrophoresis, and electroelution of the 
7.9-kb SPV DNA fragment. This BPV 
probe is contaminated with small 
amounts of pSR DNA. The starting 
DNAs for each clone were homogeneous. 
Spurious bands in the blot probably rep­
resent artefacts induced by digestion. 
Panels A, B, and C represent ethidium 
bromide-stained gels. Panels A " B', and 
C' represent the autoradiograms result­
ing from the hybridizations. In each 
panel, lanes I through 7 represent dele­
tion clones DC 1-7, respectively. Lane 8 
represents the starting wild-type BPV­
'pBR DNA, and lane 9 in panel A repre­
sents this starting DNA digested with 
Sail, which cleaves the DNA only once 
(in pSR322). The numbers beside the 
gels represent the length in kilobases of 
various fragments. The schematic draw­
ing at the bottom of the figure represents 
the physical map of the BPV /pBR322 
starting DNA cleaved at one BamHI 
site. The sizes of the different fragments 
are indicated in kilobases. 
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pBR or BPY DNA) were then ligated to each end, although this 
procedure was only successful in some mutants (see below, under 
mapping of the mutants). The DNAs were then digested with XhoI 
restriction endonuclease, recircularized with T4 ligase, and then used 
to transform E. coli strain RR-1, which is sensitive to ampicillin. 
Colonies growing in the presence of ampicillin, which presumptively 
had received pBR322 DNA (which confers resistance to ampicillin), 
were then amplified in liquid culture and the DNAs were analyzed. 
Restriction Endonuclease A nalysis of Deletion Mutants 
Fifteen different DNAs were analyzed; seven were found to contain 
deleted BPY DNA genomes. Their preliminary restriction endonu­
clease analysis is shown in Fig 1. When the mutants were digested with 
Bam HI (Fig 1,A), which separates the BPY DNA from the pBR322 
DNA, two fragments were produced with each clone, except for clone 
DC 4 (lane 4). Bam HI cleaved DC 4 only once; 0.9 kb was deleted from 
this clone, as shown by comparison with the wild-type clone digested 
with a single-cut restriction endonuclease (lane 9). The 4.3-kb fragment 
found in every mutant except DC 4 represented pBR322, while the 
second fragment represented the BPY DNA sequences. In each instance 
this second fragment was shorter than the 7.9-kb wild-type BPY DNA 
genome, showing that these BPY DNAs were deleted (Fig 1,A, lane 8). 
The BPY DNA fragments were positively identified by Southern trans­
fer of the DNA and hybridization to a 32P-labeled BPY DNA probe 
(Fig 1,A ') [14). The results indicated that the deletions were confined 
to BPY DNA sequences in each of the 7 mutants, except DC 4, which 
contained a deletion in adjacent pBR and BPY DNA sequences sur­
rounding the deleted BamHI site. 
The locations of the deletions were further defined by double diges­
tion with BamHI and each of two other restriction endonucleases 
(HindIII EcoRI) that cleave BPY DNA once (Fig 1,B,C). BamHI/ 
HindIII digestion of BPY genomic DNA yields two fragments: 2.5 kb 
and 5.4 kb (Fig 1,C, lane 8). The larger BamHI/HindIII fragment is 
the previously established 69% transforming fragment. Since clones 
DC 1, 2, 6, and 7 contained the 2.5-kb BamHI/HindIII fragment and 
a second BPY fragment shorter than 5.4 kb, the deletions in these four 
clones were confined entirely to the 69% transforming fragment. The 
BPY DNA sequences of clones DC 3 and 5 were not cleaved by HindIII, 
indicating that their deletions spanned the BPY HindIII site. Clone 
DC 4 contained the 5.4-kb BamHI/HindIII BPY fragment, thus local­
izing its delected sequences to the extreme left-hand end of the BPY 
DNA genome. 
BamHI/EcoRI digestion of the DNAs (Fig 1,B) cleaves the full­
length BPY DNA into 5.6- and 2.3-kb fragments (Fig 1,B, lane 8). 
Since clones DC 1 and 2 contain the 2.3-kb fragment, this result 
indicated that in these two clones the deleted sequences within the 
69% fragment were located between the HindIII and EcoRI sites. 
Conversely, the deletion in clones DC 6 and 7 (which appear to be 
identical) involved most of the 69% fragment and spanned the viral 
EcoRI site. When the viral DNAs were digested with BamHI/XhoI, 
clones 5, 6, and 7 were found to contain added XhoI sites (data not 
shown). This double digestion combined with the previously described 
digestions immediately localized the deleted DNA segments in these· 
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three clones to the regions shown schematically in Fig 2. The precise 
locations of the deletions shown in Fig 2 for the other four clones were 
based on further digestions with other restriction endonucleases whose 
locations in the BPY DNA genome have been previously determined 
[13). 
Construction of Clone pHLBI (LTR-BPV) 
This clone, which contains the long terminal repeat (L TR) of Harvey 
murine sarcoma virus (Ha-MuSY) [15,16) ligated to the 2.3-kb EcoRI/ 
BamHI fragment of BPY (see bottom of Fig 1) in pBR322, was derived 
as follows. The 2.3-kb EcoRI/BamHI fragment from the 3' end of the 
69% transforming fragment of BPY DNA was first subcloned in 
pBR322 at the EcoRI and BamHI sites. This clone (pBEB1) was then 
linearized by digestion with EcoRI. A previously described circularly 
permuted L TR from Ha-MuSY that contained EcoRI ends (clone 
HLTR) [16) was then inserted at the EcoRI site of this pBR·BPY 
plasmid. The correct (promoter plus) orientation of the L TR sequences 
was verified by KpnI digestion; this L TR BPY clone is designated 
pHLB1. 
DNA Infectivity 
DNA infectivity assays (transfections) were carried out on mouse 
NIH 3T3 cells as previously described [17,18). Except as noted, the 
DNAs were digested with BamHI prior to transfection. 
RESULTS 
Using the BPV transformation assay described earlier, the 
capacity of BPV DNA to induce cellular transformation was 
previously localized to a 5.4-kb BamHI/HindIII DNA fragment 
that represents 69% of the 7.9-kb full-length viral genome [6]. 
Further analysis has indicated that the transformed cells con­
tain several polyadenylated viral RNA species [19-21]. The 
bodies of these RNAs map within the 69% transforming frag­
ment; they vary in size from 1-5 kb; their 3' terminals (right­
ward ends) map to a common site about 0.3 kb upstream from 
the BamHI site; and their 5' ends (leftward) are toward the 
HindIII end. The sequences that encode the structural virion 
proteins are located within the 31% fragment that is not 
required for transformation; RNA from this region is not found 
in the transformed cells, which accounts for the failure to detect 
virion proteins in the cells. 
Generation of BPV DNA Deletion Mutants 
In order to further characterize the transforming function of 
the BPV DNA, we created several more deletion mutants of 
the viral DNA. The capacity of these DNAs to induce cellular 
transformation in mouse cells has been correlated with the size 
and location of the deletions. The starting materials for these 
deletions was the BPV DNA genome molecularly cloned at the 
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BamHI site in the bacterial plasmid pBR322. Seven deletion 
mutants were obtained and characterized (clones DC 1-7) by 
restriction endonuclease digestion, as described in Methods. 
The location of the deleted sequences in each mutant is shown 
schematically in Fig 2. 
Transforming Activity of BPV Deletion Mutants 
The infectivity of the DNAs on NIH 3T3 mouse cells was 
then determined (Fig 2). Prior to adding the DNAs to the cells, 
the DNAs were digested with BamHI to separate the BPY and 
pBR sequences, since linkage of pBR sequences to BPY inhibits 
BPY-induced transformation [6,22]. Clones DC 1 and 2 yielded 
about two-thirds as many foci per microgram of viral DNA as 
did wild-type BPY DNA. Compared with foci induced by the 
full-length viral DNA or the HindIII/Bam HI 69% transform­
ing fragment, the foci induced by clones DC 1 and 2 appeared 
1-2 days later and developed more slowly (Fig 3). Transform­
ants induced by clones DC 1 and 2 also grew less efficiently in 
0.35% agar and formed tumors more slowly in nude mice. Clone 
DC 4, which contained only one Bam HI site, yielded very few 
foci, presumably the consequence of continued covalent linkage 
of pBR322 and BPY DNA sequences. The other deletion mu­
tants were not infectious. 
Infectivity of Subgenomic Fragments of the Mutants 
Since the deleted 2.2 kb in the infectious clone DC 2 included 
all those sequences deleted in clone DC 1, we focused our 
attention on the sequences in clone DC 2. This mutant is 
composed of two linked BPY DNA segments: a 3.1-kb leftward 
one and a 2.7-kb rightward one. It may be noted in Fig 2 that 
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FIG 3. Photographs of Giemsa-stained cells in GO-mm Petri dishe� 
that had been transfected with the indicated DNA 18 days previously. 
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the noninfectious clone DC 5 appears to contain the same 2.7-
kb rightward BPY DNA segment as clone DC 2, while nonin­
fectious clones DC 6 and 7 appear to contain the same 3.1-kb 
leftward segment as clone DC 2. It therefore seemed likely that 
the positive results obtained with clone DC 2 were because 
sequences from both the leftward and the rightward segments 
were required for transformation by clone DC 2. 
In order to test this hypothesis directly, the rightward 2.7 -kb 
XhoI/Bam HI fragment of clone DC 5 and the leftward 3.1-kb 
BamHI/XhoI fragment of clone DC 6 were isolated. These 
DNAs were then ligated either to themselves or to each other 
and added to the NIH 3T3 cells. As shown in Table I, the 
fragments from clones DC 5 and 6, when ligated to each other, 
induced focal cellular transformation, although each fragment 
by itself lacked this capacity. The data also indicated that 
covalent linkage of the two fragments was required, that is, the 
fragments would act only in cis (linked to each other), since 
addition of the two fragments together without ligation yielded 
only a single focus. Further analysis of this focus revealed that 
the two fragments were covalently linked in the transformant 
derived from this focus. These results then indicated that 
sequences from both fragments were required for the induction 
of transformation by BPY DNA. Since these sequences in the 
full-length viral DNA are separated by at least 2.2 kb, these 
results indicate that discontinuous sequences are required for 
transformation. 
Function of the Rightward BPV Fragment 
Because the 3' ends of the viral RNA transcripts in trans­
formed cells are near the viral BamHI site in the 69% trans­
forming fragment [19,20], it seemed reasonable to hypothesize 
that the segment located near the HindIII site contains control 
elements of the viral DNA, such as sequences for enhancement, 
promotion, and/or initiation of RNA synthesis. Sequences lo­
cated toward the EcoRI/BamHI end presumably encode a 
transforming protein or proteins of BPY. In order to test this 
hypothesis, we attempted to see if a known viral control ele­
ment, the long terminal repeat (L TR) of a murine retroviral 
DNA [23-25], could substitute for the sequences located near 
the HindIII site of BPY DNA. Previous studies had shown that 
the L TR was necessary for the sequences encoding the trans­
forming protein of acute transforming retroviruses to induce 
cellular transformation efficiently [23,24]. 
We therefore constructed a clone in pBR322 of a retroviral 
L TR and the rightward 2.3-kb Eco RI/ BamHI fragment of BPY 
DNA (see Methods). When this LTR BPY clone (pHLB1) was 
tested for its capacity to transform NIH 3T3 cells, it yielded 
almost 2000 foci/J.Lg DNA (Fig 3). This DNA was infectious 
even when the viral DNA sequences were not separated from 
the pBR DNA. These results, therefore, formally support the 
hypothesis that transforming sequences of BPY DNA lie within 
the 2.3-kb EcoRI/BamHI segment. 
TABLE 1. Structure of BPV DNA fragments 
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DISCUSSION 
These studies have characterized in further detail some func­
tional properties of different regions of the BPV DNA genome. 
Previous studies had indicated that no more than 69% of the 
BPV DNA genome (the 5.4-kb HindIII/BamHI fragment) was 
required for BPV -mediated transformation, although the effi­
ciency of this transformation was less than that obtained with 
full-length genomic DNA [6]. The current studies indicate that 
deletion of a large segment within the 69% transforming frag­
ment does not abolish the transforming capacity of the viral 
DNA. Cells transformed by such deleted viral DNA molecules 
do not grow as efficiently in agar and take longer to form 
palpable tumors in mice than do cells transformed by wild-type 
viral DNA. Other studies [10] have shown that cells trans­
formed by the deletion mutant that lacks 2.2 kb within this 
region (clone DC 2) contain lower numbers of viral DNA copies 
compared with full-length viral DNA, which correlates with 
their lower oncogenicity. It is also possible that the deleted 
sequences may contribute directly to the fully transformed 
phenotype. 
In addition to showing that sequences within the 69% trans­
forming fragment are not required for BPV -induced transfor­
mation, the results indicate the sequences to the left and to the 
right of the deleted segment are both required (in cis) for viral­
induced transformation. Our data have also given some insight 
into the function of these nondeleted sequences in clone DC 2 
(Fig 4). It is likely that portions of the leftward segment (which 
includes the viral HindIII site) function as a transcription 
control element within the viral genome. One study [19] of the 
viral RNAs in BPV -transformed cells suggested that even the 
transcripts that were smaller than 2 kb were composed of 
spliced RNAs that contained sequences from this region, while 
a second study [20] failed to detect such splicing, although a 
small 5' leader sequence might not have been detected. Spliced 
RNA transcripts have been detected in cottontail rabbit 
(Shope) papillomavirus-induced warts [26]. 
A retroviral L TR, which is a known viral control element 
containing sequences for enhancement, promotion, and initia­
tion of RNA transcription [25,27], can substitute functionally 
for the leftward BPV DNA segment in that either the leftward 
BPV segment or the L TR enables the rightward BPV segment 
to transform the mouse cells. This substitution is not exact: 
The retroviral L TR plus the rightward BPV fragment can be 
infectious even when the sequences are covalently linked to 
pBR322 sequences, whereas covalently linked pBR DNA inhib­
its transformation induced by wild-type BPV DNA. 
ORGANIZATION OF BPV DNA TRANSFORMING REGION 
GamHI HinrJl1i EcoRI 
Full Length BPV DNA Genome 
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-
CONTROL 
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I kllobilse 
TRANSFORMING 
PROTEIN(S) 
FIG 4. Probable location of a control element and transforming 
region within the BPV genome. These may not represent the only 
functions within these regions. The control element probably extends 
to the left of the viral HindIIl site. 
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The sequences located within the rightward 2.3-kb EcoRI/ 
BamHI fragment apparently encode a transforming function 
of the BPV DNA. In addition to containing the common 3' end 
of the polyadenylated RNAs in cells transformed by viral DNA, 
this segment contains three potential open reading frames of 
300 N or greater [13]. The transforming capacity of this BPV 
fragment (when linked to the LTR) suggests, by analogy with 
other tumor viruses, that one or more of these open reading 
frames encodes a transforming protein. 
REFERENCES 
1. Melnick JL, Allison AC, Butel JS, Eckhart W, Eddy BE, Kit S, 
Levine JJ, Miles AJR, Pagano JS, Sachs L, Vonka V: Papova­
viridae. Intervirology 3:106-120,1974 
2. Orth G, Favre M, Breitburd F, Croissant 0, Jablonska S, Obalek 
S, Jarzabek-Chorazelska M, Rzesa G: Epidermodysplasia verru­
ciformis: A model for the role of papilloma viruses in human 
cancer, Cold Spring Harbor Symposium on Viruses in Naturally 
Occurring Cancer, vol 7. Edited by M Essex, G Todaro, H zur 
Hausen. Cold Spring Harbor, New York, Cold Spring Harbor 
Laboratory, 1980, pp 259-282 
3. Lancaster WD, Olson C: Animal papillomaviruses. Microbiol Rev 
46:191-207,1982 
4. Dvoretzky I, Shober R, Chattopadhyay SK, Lowy DR: A quanti­
tative in vitro focus assay for bovine papillomavirus. Virology 
103:369-375, 1980 
5. Watts SL, Ostrow RS, Phelps WC, Prince JT, Faras AJ: Free 
cottontail rabbit papillomavirus DNA persists in warts and 
carcinomas of infected rabbits and in cells in culture transformed 
with virus or viral DNA. Virology 125:127-138, 1983 
6. Lowy DR, Dvoretzky I, Shober R, Law M-F, Engel L, Howley PM: 
In vitro tumorigenic transformation by a defined subgenomic 
fragment of bovine papillomavirus DNA. Nature 287:72-74, 1980 
7. Lancaster WD: Apparent lack of integration of bovine papilloma­
virus DNA in virus-induced equine and bovine tumors and virus­
transformed mouse cells. Virology 108:251-255, 1981 
8. Law M-F, Lowy DR, Dvoretzky I, Howley PM: Mouse cells trans­
formed by bovine papillomavirus contain only extrachromosomal 
viral DNA sequences. Proc Natl Acad Sci USA 78:2727-2731, 
1981 
9. Danos 0, Engel LW, Chen EY, Yaniv M, Howley PM: Comparative 
analysis of the human type 1 a and bovine type 1 papillomavirus 
genomes. J Virol 46:557-566, 1983 
10. Nakabayashi Y, Chattopadhyay SK, Lowy DR: The transforming 
function of bovine papillomavirus DNA. Proc Nat! Acad Sci 
USA 80:5832-5836, 1983 
11. Howley PM, Law M-F, Heilman CA, Engel LW, Alonso MC, 
Lancaster WD, Israel MA, Lowy DR: Molecular Characteriza­
tion of papillomavirus genomes, Viruses in Naturally Occurring 
Cancers, vol 7. Edited by M Essex, G Todaro, H zur Hausen. 
Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 
1980, pp 233-247 
12. Heffron F, So M, McCarthy BJ: In vitro mutagenesis of circular 
DNA molecule by using synthetic restriction sites. Proc Natl 
Acad Sci USA 75:6012-6016, 1978 
13. Chen EY, Howley PM, Levinson AD, Seeburg PH: The primary 
structure and genetic organization of the bovine papillomavirus 
type I genome. Nature 299:529-534, 1982 
14. Southern EM: Deletion of specific sequences among DNA frag­
ments separated by gel electrophoresis. J Mol Bioi 98:503-517, 
1975 
15. Hager GL, Chang EH, Chan HW, Garon CF, Israel MA, Martin 
MA, Scolnick EM, Lowy DR: Molecular cloning of the Harvey 
sarcoma virus closed circular DNA intermediates: Initial struc­
tural and biological characterizations. J Virol 31:795-809, 1979 
16. Chang EH, Gonda MA, Ellis RW, Scolnick EM, Lowy DR: Human 
genome contains four genes homologous to transforming genes 
of Harvey and Kirsten murine sarcoma viruses. Proc Nat! Acad 
Sci USA 79:4848-4852, 1982 
17. Graham FJ, van der Eb AJ: Transformation of rat cells by DNA 
of human adenovirus 5. Virology 52:456-461, 1973 
18. Lowy DR, Rands E, Scolnick EM: Helper-independent transfor­
mation by unintegrated Harvey sarcoma virus DNA. J Virol 
26:291-298,1978 
19. Amtmann E, Sauer G: Bovine papilloma virus transcription: Po­
Iyadenylated RNA species and assessment of the direction of 
transcription. J Virol 43:9-66, 1981 
20. Heilman CA, Engel LA, Lowy DR, Howley PM: Virus-specific 
transcription in bovine papillomavirus-transformed mouse cells. 
Virology 119:22-34, 1982 
21. Engel LW, Heilman CA, Howley PM: Transcriptional organization 
of bovine papillomavirus type 1. J ViroI 47:516-528, 1983 
22. Sarver N, Byrne JC, Howley PM: Transformation and replication 
July 1984 
in mouse cells of a bovine papiliomavirus/pML2 plasmid vector 
that can be rescued in bacteria. Proc Nat! Acad Sci USA 79:7147-
7151 
23. Blair DG, McClements WL, Oskarsson MK, Fischinger PJ, Vande 
Woude GF: Biological activity of cloned Moloney sarcoma virus 
DNA: Terminally redundant sequences may enhance transfor­
mation efficiency. Proc Natl Acad Sci USA 77:3504-3508, 1980 
24. Chang EH, Ellis RW, Scolnick EM, Lowy DR: Transformation by 
cloned Harvey murine sarcoma virus DNA: Efficiency increased 
by long terminal repeat DNA. Science 210:1249-1251,1980 
IN VITRO TRANSFORMATION BY BPV 17s 
25. Kriegler M, Botchan M: Enhanced transformation by a simian 
virus 40 recombinant virus containing a Harvey murine sarcoma 
virus long terminal repeat. Mol Cell Bioi 3:325-339, 1983 
26. Nasseri M, Wettstein FO, Stevens JG: Two colinear and spliced 
viral transcripts are present in non-virus-producing benign and 
malignant neoplasms induced by the Shope (rabbit) papilloma 
virus. J Virol 44:263-268, 1982 
27. Levinson B, Khoury G, Vande Woude GF, Gruss P: Activation of 
SV40 genome by 72-base pair tandem repeats of Moloney sar­
coma virus. Nature 295:568-572, 1982 
